Development of admixture mapping panels for African Americans from commercial high-density SNP arrays
Authors:
- Guanjie ChenGCGuanjie Chen
- Daniel ShrinerDSDaniel Shriner
- Jie ZhouJZJie Zhou
- Ayo DoumateyADAyo Doumatey
- Hanxia HuangHHHanxia Huang
- Norman P GerryNGNorman P Gerry
- Alan HerbertAlan Herbert
- Michael F ChristmanMCMichael F Christman
- Yuanxiu ChenYCYuanxiu Chen
- Georgia M DunstonGDGeorgia M Dunston
- Mezbah U FaruqueMFMezbah U Faruque
- Charles N RotimiCRCharles N Rotimi
Open Access
- 5 July 2010
- journal article
- research article
- Published by Springer Nature in BMC Genomics
- Vol. 11 (1) , 417
Abstract
Background: Admixture mapping is a powerful approach for identifying genetic variants involved in human disease that exploits the unique genomic structure in recently admixed populations. To use existing published panels of ancestry-informative markers (AIMs) for admixture mapping, markers have to be genotyped de novo for each admixed study sample and samples representing the ancestral parental populations. The increased availability of dense marker data on commercial chips has made it feasible to develop panels wherein the markers need not be predetermined. Results: We developed two panels of AIMs (~2,000 markers each) based on the Affymetrix Genome-Wide Human SNP Array 6.0 for admixture mapping with African American samples. These two AIM panels had good map power that was higher than that of a denser panel of ~20,000 random markers as well as other published panels of AIMs. As a test case, we applied the panels in an admixture mapping study of hypertension in African Americans in the Washington, D.C. metropolitan area. Conclusions: Developing marker panels for admixture mapping from existing genome-wide genotype data offers two major advantages: (1) no de novo genotyping needs to be done, thereby saving costs, and (2) markers can be filtered for various quality measures and replacement markers (to minimize gaps) can be selected at no additional cost. Panels of carefully selected AIMs have two major advantages over panels of random markers: (1) the map power from sparser panels of AIMs is higher than that of ~10-fold denser panels of random markers, and (2) clusters can be labeled based on information from the parental populations. With current technology, chip-based genome-wide genotyping is less expensive than genotyping ~20,000 random markers. The major advantage of using random markers is the absence of ascertainment effects resulting from the process of selecting markers. The ability to develop marker panels informative for ancestry from SNP chip genotype data provides a fresh opportunity to conduct admixture mapping for disease genes in admixed populations when genome-wide association data exist or are planned.Keywords
This publication has 42 references indexed in Scilit:
- Admixture Mapping of Obesity‐related Traits in African Americans: The Atherosclerosis Risk in Communities (ARIC) StudyObesity, 2010
- Results from a prostate cancer admixture mapping study in African-American menHuman Genetics, 2009
- Admixture Mapping of Quantitative Trait Loci for BMI in African Americans: Evidence for Loci on Chromosomes 3q, 5q, and 15qObesity, 2009
- MYH9 is associated with nondiabetic end-stage renal disease in African AmericansNature Genetics, 2008
- MYH9 is a major-effect risk gene for focal segmental glomerulosclerosisNature Genetics, 2008
- Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVsNature Genetics, 2008
- A Genome-wide Analysis of Admixture in Uyghurs and a High-Density Admixture Map for Disease-Gene DiscoveryThe American Journal of Human Genetics, 2008
- Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in AmericaHuman Mutation, 2008
- Admixture Mapping of White Cell Count: Genetic Locus Responsible for Lower White Blood Cell Count in the Health ABC and Jackson Heart StudiesThe American Journal of Human Genetics, 2008
- Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American menProceedings of the National Academy of Sciences, 2006